Allworth Financial’s Entera Bio ENTX Stock Holding History

Allworth Financial’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	–	–	1584
2021 Q1	$0	Buy	+100	New	+$230	﹤0.01%	1523

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Allworth Financial's ENTX Position: Q2 2021 in Review

Allworth Financial sold out of Entera Bio (ENTX) in Q2 2021, closing a stake of 100 shares.

Allworth Financial first reported a position in ENTX in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 14 funds tracked by Wall St. Rank hold ENTX as of Q2 2021.

Allworth Financial reported no remaining Entera Bio position as of Q2 2021 after selling out during the quarter.
Allworth Financial sold 100 Entera Bio shares in Q2 2021.
Allworth Financial first reported a position in Entera Bio in Q1 2021 and held it in 1 quarter.
Allworth Financial's Entera Bio position peaked at $0 in Q1 2021.
14 funds tracked by Wall St. Rank held Entera Bio as of Q2 2021.

Based on Allworth Financial's 13F filing for Q2 2021, filed 2 Aug 2021.